Debt-to-Equity Ratio

The debt-to-equity ratio compares total debt to shareholders' equity, showing how much a company relies on borrowed money versus investor funds; a ratio of 1.35x means Bayer has $1.35 in debt for every $1 of equity.

That level is nearly three times the sector median of 0.45x, placing Bayer in the 81st percentile among healthcare peers, meaning it carries more debt than 81% of comparable companies. No trend data is available, as the year-over-year change is N/A and the quarter-over-quarter change is also N/A, leaving the metric's recent trajectory unknown. The elevated ratio combined with missing trend information implies elevated financial leverage compared to peers, which adds risk if earnings weaken, but without a trend direction the near-term risk cannot be assessed. This metric contradicts the overall NEUTRAL verdict, because a debt-to-equity ratio well above the sector median typically signals a higher-risk capital structure that would warrant a more cautious view.

Frequently Asked Questions

Closest Sector Peers